Toronto, Ontario--(Newsfile Corp. - October 4, 2024) - Awakn Life Sciences Corp. (AWKN:CA) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company focused on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback